Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PEComa”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Testing effectiveness (Phase 2)Looking for participantsNCT07089992
What this trial is testing

Pembrolizumab in People With Ultra-Rare Sarcomas

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center 32
Not applicableUnknownNCT05617105
What this trial is testing

Molecular Characterization of Perivascular Epithelioid Cell Tumors

Who this might be right for
Perivascular Epithelioid Cell Tumor, Malignant
University Hospital, Strasbourg, France 100
Not applicableActive Not RecruitingNCT06453642
What this trial is testing

Evaluation of a Simple-Prep Controlled Embolic

Who this might be right for
EmbolizationVascular TumorRenal Angiomyolipoma+3 more
Fluidx Medical Technology, Inc. 114
Testing effectiveness (Phase 2)Study completedNCT02494570
What this trial is testing

Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComa

Who this might be right for
Malignant PEComa
Aadi Bioscience, Inc. 34
Not applicableActive Not RecruitingNCT07538908
What this trial is testing

Superselective Renal Artery Embolization for Renal Angiomyolipoma

Who this might be right for
Selective Endovascular Embolization of Kidney Artery
Botkin Hospital 50
Testing effectiveness (Phase 2)Study completedNCT03131999
What this trial is testing

LAM Pilot Study With Imatinib Mesylate

Who this might be right for
Lymphangioleiomyomatosis
Medical University of South Carolina 18
Not applicableStudy completedNCT02009241
What this trial is testing

Pulmonary Rehabilitation in Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
University of Sao Paulo General Hospital 40
Not applicableStudy completedNCT00960895
What this trial is testing

Pulmonary Hypertension in Lymphangioleiomyomatosis

Who this might be right for
LymphangioleiomyomatosisPulmonary Hypertension
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires 20
Testing effectiveness (Phase 2)Study completedNCT00005906
What this trial is testing

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

Who this might be right for
LymphangioleiomyomatosisLymphangiomyomasPleural Effusions+1 more
National Heart, Lung, and Blood Institute (NHLBI) 4
Not applicableApproved For MarketingNCT03817515
What this trial is testing

Expanded Access for ABI-009 in Patients With Advanced PEComa and Patients With a Malignancy With Relevant Genetic Mutations or mTOR Pathway Activation

Who this might be right for
PEComa, MalignantTSC1TSC2+1 more
Aadi Bioscience, Inc.
Not applicableEnded earlyNCT02654340
What this trial is testing

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Who this might be right for
Hypomelanotic MaculesFacial AngiofibromaShagreen Patches+6 more
CENTOGENE GmbH Rostock 20
Large-scale testing (Phase 3)Ended earlyNCT02929394
What this trial is testing

Trabectedin Maintenance Post 1st-line in STS

Who this might be right for
Sarcoma, Soft Tissue
European Organisation for Research and Treatment of Cancer - EORTC 13
Testing effectiveness (Phase 2)UnknownNCT05625919
What this trial is testing

Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)

Who this might be right for
Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 54
Large-scale testing (Phase 3)Study completedNCT02180867
What this trial is testing

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

Who this might be right for
Alveolar Soft Part SarcomaAngiomatoid Fibrous HistiocytomaAtypical Fibroxanthoma+33 more
National Cancer Institute (NCI) 140
Very early researchUnknownNCT05087134
What this trial is testing

Characterizing LAM With 11C-Choline PET/CT

Who this might be right for
Lymphangioleiomyomatosis
Peking Union Medical College Hospital 50
Not applicableStudy completedNCT02334930
What this trial is testing

Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors

Who this might be right for
PEComaHemangioma
University Hospital, Bordeaux 13
Not applicableLooking for participantsNCT00001465
What this trial is testing

Study of the Disease Process of Lymphangioleiomyomatosis

Who this might be right for
Lung DiseasePneumothoraxTuberous Sclerosis+1 more
National Heart, Lung, and Blood Institute (NHLBI) 2,000
Not applicableActive Not RecruitingNCT06126159
What this trial is testing

MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers

Who this might be right for
Kidney Neoplasms
Chang Gung Memorial Hospital 44
Testing effectiveness (Phase 2)Study completedNCT03304678
What this trial is testing

Discovery of Sirolimus Sensitive Biomarkers in Blood

Who this might be right for
Lymphangioleiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 33
Not applicableUnknownNCT03916575
What this trial is testing

PEComas: Natural History and Prognostic Factors

Who this might be right for
PEComas
University Hospital, Strasbourg, France 60
Next Page